Unknown

Dataset Information

Loss of MK2 Enhances Radiation-Mediated Apoptosis in Bladder Cancer.


ABSTRACT:

Background

Bladder cancer patients unable to receive cystectomy or who choose to pursue organ-sparing approach are managed with definitive (chemo)radiotherapy. However, this standard of care has not evolved in decades and disease recurrence and survival outcomes remain poor. Identifying novel therapies to combine with radiotherapy (RT) is therefore paramount to improve overall patient outcomes and survival. One approach is to find cellular mechanisms that can be targeted to increase the radiosensitivity of bladder cancer. The stress-activated kinase directly downstream from p38 mitogen-activated protein kinase (MAPK), mitogen-activated protein kinase activated protein kinase 2 (MAPKAPK2 or MK2), has been shown to enhance cancer-mediated inflammation, mesenchymal gene expression, an

SUBMITTER: Morgan D 

PROVIDER: S-EPMC11650613 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature